Challenges in treatment of hepatitis C among patients with hepatocellular carcinoma

Hepatology. 2017 Aug;66(2):661-663. doi: 10.1002/hep.29126. Epub 2017 Jun 24.

Authors

Behnam Saberi¹, Alia S Dadabhai¹, Christine M Durand², Benjamin Philosophe³, Andrew M Cameron³, Mark S Sulkowski², Ahmet Gurakar¹

Affiliations

¹ The Johns Hopkins University School of Medicine, Division of Gastroenterology and Hepatology, Baltimore, MD.
² The Johns Hopkins University School of Medicine, Division of Infectious Disease, Baltimore, MD.
³ The Johns Hopkins University, Department of Transplant Surgery, Baltimore, MD.

PMID: 28211073
DOI: 10.1002/hep.29126

No abstract available

MeSH terms

Aged
Antiviral Agents / therapeutic use*
Carcinoma, Hepatocellular / complications
Female
Hepatitis C / complications
Hepatitis C / drug therapy*
Humans
Liver Neoplasms / complications
Male
Middle Aged

Substances

Antiviral Agents

Grants and funding

K24 DA034621/DA/NIDA NIH HHS/United States